HCONRES 320
107th Congress
House
Health
Autoimmune diseases
Commemorations
Communication in medicine
Communication in science
Conferences
Congress
Congressional tributes
Economics and Public Finance
Environmental Protection
Environmental research
Environmentally induced diseases
Epidemiology
Federal aid to medical research
Genetic research
Government Operations and Politics
Health education
Health surveys
Human genetics
Medical genetics
Expressing the sense of the Congress regarding scleroderma.
Everywhere this bill has been
14 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Sep 11, 2002
Referred to the Committee on Health, Education, Labor, and Pensions.
Sep 10, 2002
The title of the measure was amended. Agreed to without objection.
Sep 10, 2002
Motion to reconsider laid on the table Agreed to without objection.
Sep 10, 2002
On motion to suspend the rules and agree to the resolution, as amended Agreed to by the Yeas and Nays: (2/3 required): 369 - 2 (Roll no. 383). (text: CR H6146)
Sep 10, 2002
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Sep 10, 2002
DEBATE - The House proceeded with forty minutes of debate on H. Con. Res. 320.
Sep 10, 2002
Considered under suspension of the rules. (consideration: CR H6146-6147, H6148-6149)
Sep 10, 2002
Mr. Fossella moved to suspend the rules and agree to the resolution, as amended.
Sep 5, 2002
Ordered to be Reported in the Nature of a Substitute by Voice Vote.
Sep 5, 2002
Committee Consideration and Mark-up Session Held.
Mar 5, 2002
Referred to the Subcommittee on Health.
Feb 14, 2002
Sponsor introductory remarks on measure. (CR E161)
Feb 7, 2002
Referred to the House Committee on Energy and Commerce.
Feb 7, 2002
Introduced in House
Votes taken on this bill
1
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Sep 10, 2002 | House · vote #383 | On Motion to Suspend the Rules and Agree, As Amended | Passed | 369–2 | See who voted → |
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Calls for: (1) recognition of private organizations and health care providers for promoting awareness and research on scleroderma; (2) greater awareness of the symptoms of scleroderma and contributions to the fight against it; (3) the National Institutes of Health to continue to take a leadership role in research efforts regarding the fight against scleroderma and to allow for broad dissemination of the information learned from such research; and (4) the Centers for Disease Control and Prevention to consider additional methods to improve disease surveillance of scleroderma.
What's happening now
Referred to the Committee on Health, Education, Labor, and Pensions.
Bill text
3 versions
- Engrossed in House Formatted Text PDF
- Introduced in House Formatted Text PDF
- Referred in Senate Formatted Text PDF
Committees of jurisdiction
3
Cite this page
U.S. Congress. (2026). H. Con. Res. 320: Expressing the sense of the Congress regarding scleroderma.. 107th Congress. Open America. https://openamerica.io/bill/107-HCONRES-320/
"H. Con. Res. 320: Expressing the sense of the Congress regarding scleroderma.." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HCONRES-320/.
H. Con. Res. 320, 107th Cong. (2026), https://openamerica.io/bill/107-HCONRES-320/.
[H. Con. Res. 320: Expressing the sense of the Congress regarding scleroderma.](https://openamerica.io/bill/107-HCONRES-320/)